| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |